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In their recent commentary, Vernillo and coworkers [1] argue
that disclosure of a critically ill patient’s HIV status to a
surrogate is appropriate when ‘necessary for the surrogate to
make decisions that reflect the patient’s values and interests,
or when failure to disclose poses direct and foreseeable risks
to the surrogate.’
Although few would disagree with the latter precept, the
ethical and legal permissibility of the former is less obvious
[2]. Dispensing with patient confidentiality under the rubric of
‘beneficence’ does not guarantee preferable end-of-life
outcomes. Even if the emotional impact of this disclosure has
minimal influence on surrogates’ decision making abilities,
they are, ceteris paribus, left no better informed of their loved
one’s wishes than before.
HIV-infected patients may have various rational reasons for
refusing to disclose their seropositivity or declining anti-
retroviral treatment, which are unlikely to be easily divined by
most critical care teams. What is known about many of these
patients is that they have chosen to keep their HIV status
confidential, often at great sacrifice. Surmising that they favor
‘the timely withdrawal of painful or futile interventions’ -
precisely when these patients can no longer speak for
themselves - both begs the question and stretches the
bounds of human inference.
The authors’ proposed framework for disclosing privileged
information risks positing knowledge of patients’ attitudes
and beliefs where there is none and threatens the privacy and
health care interests of an already vulnerable population.
Physicians must ultimately remain vigilant of unwarranted
supposition when caring for the critically ill and interacting
with their surrogates.
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Authors’ response
Anthony T Vernillo, Paul R Wolpe and Scott D Halpern
Mr Lott correctly points out that HIV-infected patients may
have rational reasons for declining antiretroviral therapy.
However, it is difficult to see how one might rationally refuse
antiretroviral medications yet desire aggressive care at the
end of life. The former suggests a limited tolerance for even
noninvasive medical intervention, whereas the latter suggests
a high tolerance for invasive interventions. Thus, determining
that a patient has chosen to forego antiretroviral therapy
clearly can assist in determining a patient’s end-of-life
preferences, and may thereby usefully inform surrogate
decision making.
Mr Lott also raises the very real concern about the range of
inferences that intensivists and surrogates might make
regarding the treatment preferences of a critically ill patient.
Unfortunately, he fails to appreciate the reality of critical care -
that physicians and surrogates often have to make ‘best
guesses’ as to patients’ end-of-life treatment preferences.
There is often no alternative, and decisions sometimes must
be made with limited information [3,4]. This is regrettable, but
to deny the ability to limit invasive interventions under
conditions of limited knowledge is to deny the possibility of
providing palliative care. We believe that it is not only wholly
unrealistic to require perfect knowledge of patients’ values
before implementing palliative interventions at the end of life,
but it is also potentially inhumane.Page 2 of 2
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Finally, Mr Lott suggests that our proposal ‘threatens the
privacy and health care interests of an already vulnerable
population’. Our recommendations are not meant to be
specific to HIV-related information, but rather to be applicable
to all health-related information that might be hidden from, but
germane to, surrogate decision makers. Just as we are
evolving to view HIV infection as being similar to other
chronic illnesses [5,6], we should also view terminal HIV-
related illness in the intensive care unit (ICU) as being similar
to other terminal illnesses in the ICU. As such, knowledge of
underlying advanced HIV disease may usefully inform
surrogate decision making in the same way that knowledge of
an underlying advanced malignancy often does.
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